世界の医薬品有効成分市場2021-2028:合成タイプ別(バイオテクノロジー、合成)、製造業者タイプ別(内部消費用、販売用)、種類別、用途別、地域別

◆英語タイトル:Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC059
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:191
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥799,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,029,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の医薬品有効成分市場規模が2028年までに3,125.6憶ドルに達すると予測しています。2021年から2028年までに年平均6.6%成長する見通しです。本調査レポートでは、医薬品有効成分の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、API成分概要、合成タイプ別(バイオテクノロジーAPI、モノクローナル抗体、組換えタンパク質、ワクチン、合成API)分析、製造業者タイプ別(内部消費用API、販売用API)分析、種類別(ジェネリックAPI、革新的API)分析、用途別(心血管疾患、腫瘍、中枢神経系・神経、整形外科、内分泌)分析、地域別分析、企業情報などを掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・競争分析
・API成分概要
・医薬品有効成分の世界市場規模:合成タイプ別(バイオテクノロジーAPI、モノクローナル抗体、組換えタンパク質、ワクチン、合成API)
・医薬品有効成分の世界市場規模:製造業者タイプ別(内部消費用API、販売用API)
・医薬品有効成分の世界市場規模:種類別(ジェネリックAPI、革新的API)
・医薬品有効成分の世界市場規模:用途別(心血管疾患、腫瘍、中枢神経系・神経、整形外科、内分泌)
・医薬品有効成分の世界市場規模:地域別
・企業情報
【レポートの概要】

Active Pharmaceutical Ingredient Market Growth & Trends

The global active pharmaceutical ingredients market size is expected to reach USD 312.56 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical ingredient (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The generic API segment is gaining share in the market owing to its cost effectiveness, which helps in catering to the needs of the rising number of patients in developing regions with a low-income population. According to the Association for Accessible Medicines (AAM), in 2017, there was a considerable rise in manufacturing units in Asia, Australia, and EU5. There has also been an increase in the market share of generic drugs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, other factors favoring India include quality raw materials and products, large workforce, vast distribution network, and government subsidies under schemes like “Make in India”.

For addressing unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In August 2019, OmniChem Private Limited was acquired by Ajinomoto Bio-Pharma Services (earlier they were in a joint venture since 2011 for the manufacturing of APIs). The acquisition was completed in June 2020.

Active Pharmaceutical Ingredient Market Report Highlights

• According to the WHO, around 17.5 million people die each year due to cardiovascular diseases, accounting for 31% of all deaths across the globe

• The growing geriatric population in Asian countries, such as Japan and China, along with high untapped opportunities, is expected to drive the market during the forecast period. It is estimated that over 20% of the Japanese population is aged 65 and above

• According to the CDC, about 795,000 people in the U.S. suffer from stroke every year, out of which 87% cases are of ischemic stroke

• Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer or country

• Key players are increasingly focusing on vaccines, for instance, Sanofi announced an investment of USD 601.37 million for vaccine production and research in France. These investments are anticipated to drive the development of new vaccine APIs in the coming years to help facilitate readiness to deliver new products

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Regional scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 Key KoL Responses
1.9 Market share calculations
1.10 List of Secondary Sources
1.11 List of Abbreviations
1.12 Objectives
1.12.1 Objective 1
1.12.2 Objective 2
1.12.3 Objective 3
1.12.4 Objective 4
Chapter 2 Executive Summary
2.1 Segment Outlook
2.2 Competitive Outlook
2.3 Market Outlook
Chapter 3 API Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Growing geriatric population
3.4.1.2 Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
3.4.1.3 Increasing preference for targeted therapy approach in cancer treatment
3.4.1.4 Increasing preference for outsourcing APIs
3.4.2 Market Restraint Analysis
3.4.2.1 High capital investments and production cost
3.4.2.2 Stringent Safety and handling regulations regarding APIs
3.5 Market Analysis Tools
3.5.1 Industry Analysis: Porter’s
3.5.2 PESTLE Analysis
3.5.3 Regulatory Scenario
Chapter 4 API Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Ansoff matrix
4.1.2 Heat map analysis
4.2 Company Categorization
4.2.1 Innovators
4.2.2 Market Leaders
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.3.3 Key company market share analysis, 2020
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company market position analysis
4.4.3 Competitive Dashboard Analysis
4.4.3.1 Market Differentiators
4.5 Private Companies
4.5.1 List of key emerging companies
4.6 Major Deals and Strategic Alliances Analysis
4.6.1 Joint Ventures
4.6.2 Acquisitions
4.6.3 Licensing and Partnerships
4.6.4 Technological Collaborations
Chapter 5 API Molecules Outlook
5.1 Global Sales of API Molecules, USD Million, 2017 – 2020
5.2 Companies with the leading market position for API molecules
5.2.1 Amoxicillin
5.2.2 Azithromycin
5.2.3 Bleomycin
5.2.4 Caspofungin
5.2.5 Clarithromycin
5.2.6 Clavulanic acid
5.2.7 Clindamycin
5.2.8 Compactin (Mevastatin)
5.2.9 Cyclosporin
5.2.10 Dactinomycin
5.2.11 Daptomycin
5.2.12 Demeclocycline
5.2.13 Doxycycline
5.2.14 Erythromycin
5.2.15 Ivermectin (Avermectin)
5.2.16 Lovastatin
5.2.17 Micafungin
5.2.18 Minocycline
5.2.19 Mitomycin
5.2.20 Mycophenolic acid
5.2.21 Pneumocandin B0
5.2.22 Polymyxin
5.2.23 Pravastatin
5.2.24 Rapamycin (Sirolimus)
5.2.25 Simvastatin
5.2.26 Steroids
5.2.27 Tacrolimus
5.2.28 Tetracycline
5.2.29 Tigecycline
5.2.30 Tobramycin
5.2.31 Vancomycin
5.3 Comparative price analysis of the above-mentioned molecules
Chapter 6 API Market: Segment Analysis, by Type of Synthesis, 2017 – 2028 (USD Billion)
6.1 Definition and Scope
6.2 Type of Synthesis Market Share Analysis, 2020 & 2028
6.3 Segment Dashboard
6.4 Global API Market, by Type of Synthesis, 2017 to 2028
6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
6.5.1 Biotech API
6.5.1.1 Biotech API market, 2017 – 2028 (USD Billion)
6.5.2 Monoclonal Antibodies
6.5.2.1 Monoclonal antibodies market, 2017 – 2028 (USD Billion)
6.5.3 Recombinant Proteins
6.5.3.1 Recombinant proteins market, 2017 – 2028 (USD Billion)
6.5.4 Vaccines
6.5.4.1 Vaccines market, 2017 – 2028 (USD Billion)
6.5.5 Synthetic API
6.5.5.1 Synthetic API market, 2017 – 2028 (USD Billion)
Chapter 7 API Market: Segment Analysis, by Type of Manufacturer, 2017 – 2028 (USD Billion)
7.1 Definition and Scope
7.2 Type of Manufacturer Market Share Analysis, 2020 & 2028
7.3 Segment Dashboard
7.4 Global API Market, by Type of Manufacturers, 2017 to 2028
7.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
7.5.1 Captive API
7.5.1.1 Captive API market, 2017 – 2028 (USD Billion)
7.5.2 Merchant API
7.5.2.1 Captive API market, 2017 – 2028 (USD Billion)
Chapter 8 API Market: Segment Analysis, by Type, 2017 – 2028 (USD Billion)
8.1 Definition and Scope
8.2 Type Market Share Analysis, 2020 & 2028
8.3 Segment Dashboard
8.4 Global API Market, by Type, 2017 to 2028
8.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
8.5.1 Generic APIS
8.5.1.1 Generic APIs market, 2017 – 2028 (USD Billion)
8.5.2 Innovative APIs
8.5.2.1 Innovative APIS market, 2017 – 2028 (USD Billion)
Chapter 9 API Market: Segment Analysis, by Application, 2017 – 2028 (USD Billion)
9.1 Definition and Scope
9.2 Application Market Share Analysis, 2020 & 2028
9.3 Segment Dashboard
9.4 Global API Market, by Application, 2017 to 2028
9.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
9.5.1 Cardiovascular Diseases
9.5.1.1 Cardiovascular diseases market, 2017 – 2028 (USD Billion)
9.5.2 Oncology
9.5.2.1 Oncology market, 2017 – 2028 (USD Billion)
9.5.3 CNS and Neurology
9.5.3.1 CNS and neurology market, 2017 – 2028 (USD Billion)
9.5.4 Orthopedics
9.5.4.1 Orthopedics market, 2017 – 2028 (USD Billion)
9.5.5 Endocrinology
9.5.5.1 Endocrinology market, 2017 – 2028 (USD Billion)
9.5.6 Pulmonology
9.5.6.1 Pulmonology market, 2017 – 2028 (USD Billion)
9.5.7 Gastroenterology
9.5.7.1 Gastroenterology market, 2017 – 2028 (USD Billion)
9.5.8 Nephrology
9.5.8.1 Nephrology market, 2017 – 2028 (USD Billion)
9.5.9 Ophthalmology
9.5.9.1 Ophthalmology market, 2017 – 2028 (USD Billion)
9.5.10 Others
9.5.10.1 Others market, 2017 – 2028 (USD Billion)
Chapter 10 API Market: Regional Market Analysis, 2017 – 2028 (USD Billion)
10.1 Definition & Scope
10.2 Regional Market Share Analysis, 2020 & 2028
10.3 Regional Market Dashboard
10.4 Regional Market Snapshot
10.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
10.5.1 North America
10.5.2 Europe
10.5.3 Asia Pacific
10.5.4 Latin America
10.5.5 MEA
10.6 Market Size, & Forecasts, Trend Analysis, 2020 to 2028
10.7 North America
10.7.1 North America Market estimates and forecast, 2017 – 2028 (USD Billion)
10.7.2 U.S.
10.7.2.1 U.S. API market, 2017 – 2028 (USD Billion)
10.7.3 Canada
10.7.3.1 Canada API market, 2017 – 2028 (USD Billion)
10.8 Europe
10.8.1 Europe API market, 2017 – 2028 (USD Billion)
10.8.2 U.K.
10.8.2.1 U.K. API market, 2017 – 2028 (USD Billion)
10.8.3 Germany
10.8.3.1 Germany API market, 2017 – 2028 (USD Billion)
10.8.4 Spain
10.8.4.1 Spain API market, 2017 – 2028 (USD Billion)
10.8.5 France
10.8.5.1 France API market, 2017 – 2028 (USD Billion)
10.8.6 Italy
10.8.6.1 Italy API market, 2017 – 2028 (USD Billion)
10.8.7 Russia
10.8.7.1 Russia API market, 2017 – 2028 (USD Billion)
10.9 Asia Pacific
10.9.1 Asia Pacific API market, 2017 – 2028 (USD Billion)
10.9.2 Japan
10.9.2.1 Japan API market, 2017 – 2028 (USD Billion)
10.9.3 China
10.9.3.1 China API market, 2017 – 2028 (USD Billion)
10.9.4 India
10.9.4.1 India API market, 2017 – 2028 (USD Billion)
10.9.5 South Korea
10.9.5.1 South Korea API market, 2017 – 2028 (USD Billion)
10.9.6 Australia
10.9.6.1 Australia API market, 2017 – 2028 (USD Billion)
10.10 Latin America
10.10.1 Latin America API Market, 2017 – 2028 (USD Billion)
10.10.2 Brazil
10.10.2.1 Brazil API market, 2017 – 2028 (USD Billion)
10.10.3 Mexico
10.10.3.1 Mexico API market, 2017 – 2028 (USD Billion)
10.10.4 Argentina
10.10.4.1 Argentina API market, 2017 – 2028 (USD Billion)
10.11 MEA
10.11.1 MEA API market, 2017 – 2028 (USD Billion)
10.11.2 South Africa
10.11.2.1 South Africa API market, 2017 – 2028 (USD Billion)
10.11.3 Saudi Arabia
10.11.3.1 Saudi Arabia API market, 2017 – 2028 (USD Billion)
10.11.4 UAE
10.11.4.1 UAE API market, 2017 – 2028 (USD Billion)
Chapter 11 Company Profiles
11.1 AbbVie, Inc.
11.1.1 Company overview
11.1.2 Financial performance
11.1.3 Product benchmarking
11.1.4 Strategic initiatives
11.2 Boehringer Ingelheim International GmbH
11.2.1 Company overview
11.2.2 Financial performance
11.2.3 Product benchmarking
11.2.4 Strategic initiatives
11.3 Bristol-Myers Squibb Company
11.3.1 Company overview
11.3.2 Financial performance
11.3.3 Product benchmarking
11.3.4 Strategic initiatives
11.4 Cipla, Inc.
11.4.1 Company overview
11.4.2 Financial performance
11.4.3 Product benchmarking
11.4.4 Strategic initiatives
11.5 Merck & Co., Inc.
11.5.1 Company overview
11.5.2 Financial performance
11.5.3 Product benchmarking
11.5.4 Strategic initiatives
11.6 Albemarle Corporation
11.6.1 Company overview
11.6.2 Financial performance
11.6.3 Product benchmarking
11.7 Aurobindo Pharma
11.7.1 Company overview
11.7.2 Financial performance
11.7.3 Product benchmarking
11.7.4 Strategic initiatives
11.8 Viatris Inc. (Mylan N.V.)
11.8.1 Company overview
11.8.2 Financial performance
11.8.3 Product benchmarking
11.8.4 Strategic initiatives
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Company overview
11.9.2 Financial performance
11.9.3 Product benchmarking
11.9.4 Strategic initiatives
11.10 Sun Pharmaceutical Industries Ltd.
11.10.1 Company overview
11.10.2 Financial performance
11.10.3 Product benchmarking
11.10.4 Strategic initiatives
11.11 Dr. Reddy’s Laboratories Ltd.
11.11.1 Company overview
11.11.2 Financial performance
11.11.3 Product benchmarking
11.11.4 Strategic initiatives


List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Active Pharmaceutical Ingredients Market, By Region, 2017 - 2028 (USD Billion)
TABLE 5 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 6 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 7 Global Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 8 Global Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 9 North America Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
TABLE 10 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 11 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 12 North America Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 13 North America Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 15 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 16 U.S. Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 17 U.S. Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 18 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 19 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 20 Canada Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 21 Canada Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 22 Europe Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
TABLE 23 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 24 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 25 Europe Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 26 Europe Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 27 U.K. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 28 U.K. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 29 U.K. Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 30 U.K. Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 31 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 32 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 33 Germany America Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 34 Germany America Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 35 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 36 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 37 France Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 38 France Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 39 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 40 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 41 Spain Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 42 Spain Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 43 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 44 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 45 Italy Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 46 Italy Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 47 Russia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 48 Russia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 49 Russia Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 50 Russia Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 51 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
TABLE 52 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 53 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 54 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 55 Asia Pacific Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 56 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 57 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 58 China Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 59 China Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 60 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 61 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 62 Japan Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 63 Japan Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 64 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 65 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 66 India Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 67 India Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 68 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 69 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 70 South Korea Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 71 South Korea Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 72 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 73 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 74 Australia Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 75 Australia Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 76 Latin America Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
TABLE 77 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 78 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 79 Latin America Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 80 Latin America Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 81 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 82 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 83 Brazil Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 84 Brazil Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 85 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 86 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 87 Mexico Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 88 Mexico Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 89 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 90 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 91 Argentina Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 92 Argentina Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 93 MEA Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
TABLE 94 MEA Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 95 MEA Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 96 MEA Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 97 MEA Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 98 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 99 South Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 100 South Africa Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 101 South Africa Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 102 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 103 UAE Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 104 UAE Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 105 UAE Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
TABLE 106 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
TABLE 107 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
TABLE 108 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
TABLE 109 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)

List of Figures

FIG. 1 API market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 API market, segment outlook
FIG. 10 API market, competitive outlook
FIG. 11 API market outlook (2020)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 User perspective analysis
FIG. 14 Market driver relevance analysis (Current & future impact)
FIG. 15 Global percentage of the population, by age group, 2050 and 2000
FIG. 16 Market restraint relevance analysis (Current & future impact)
FIG. 17 Porter’s five forces analysis
FIG. 18 PESTLE analysis
FIG. 19 Ansoff Matrix
FIG. 20 Heat map analysis
FIG. 21 Company market position analysis
FIG. 22 Company market position analysis
FIG. 23 Market differentiators
FIG. 24 Strategy mapping
FIG. 25 API market: Type of synthesis movement analysis
FIG. 26 Segment dashboard
FIG. 27 API market type of synthesis outlook: Key takeaways
FIG. 28 Biotech API market, 2017 - 2028 (USD Billion)
FIG. 29 Monoclonal antibodies market, 2017 - 2028 (USD Billion)
FIG. 30 Recombinant proteins market, 2017 - 2028 (USD Billion)
FIG. 31 Vaccines market, 2017 - 2028 (USD Billion)
FIG. 32 Synthetic API market, 2017 - 2028 (USD Billion)
FIG. 33 API market: Type of manufacturers movement analysis
FIG. 34 Segment dashboard
FIG. 35 API market type of manufacturers outlook: Key takeaways
FIG. 36 Captive API market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 37 Merchant API market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 38 API market: Type movement analysis
FIG. 39 Segment dashboard
FIG. 40 API market type outlook: Key takeaways
FIG. 41 Generic APIs market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 42 Innovative APIs market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 43 API market: Application movement analysis
FIG. 44 Segment dashboard
FIG. 45 API market application outlook: Key takeaways
FIG. 46 Cardiovascular diseases market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 47 Oncology market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 48 CNS & neurology market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 49 Orthopedics market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 50 Endocrinology market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 51 Pulmonology market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 52 Gastroenterology market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 53 Nephrology market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 54 Ophthalmology market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 55 Others market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 56 Regional outlook, 2020 & 2028
FIG. 57 Regional market dashboard
FIG. 58 Regional market place: Key takeaways
FIG. 59 North America, SWOT Analysis
FIG. 60 Europe, SWOT Analysis
FIG. 61 Asia Pacific, SWOT Analysis
FIG. 62 Latin America, SWOT Analysis
FIG. 63 MEA, SWOT Analysis
FIG. 64 North America
FIG. 65 North America market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 66 U.S.
FIG. 67 U.S. market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 68 Canada
FIG. 69 Canada market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 70 Europe
FIG. 71 Europe market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 72 U.K.
FIG. 73 U.K. market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 74 Germany
FIG. 75 Germany market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 76 Spain
FIG. 77 Spain market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 78 France
FIG. 79 France market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 80 Italy
FIG. 81 Italy market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 82 Russia
FIG. 83 Russia market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 84 Asia Pacific
FIG. 85 Asia Pacific market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 86 Japan
FIG. 87 Japan market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 88 China
FIG. 89 China market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 90 India
FIG. 91 India market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 92 South Korea
FIG. 93 South Korea market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 94 Australia
FIG. 95 Australia market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 96 Latin America
FIG. 97 Latin America market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 98 Brazil
FIG. 99 Brazil market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 100 Mexico
FIG. 101 Mexico market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 102 Argentina
FIG. 103 Argentina market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 104 MEA
FIG. 105 MEA market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 106 South Africa
FIG. 107 South Africa market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 108 Saudi Arabia
FIG. 109 Saudi Arabia market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 110 UAE
FIG. 111 UAE market estimates and forecast, 2017 - 2028 (USD Billion)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の医薬品有効成分市場2021-2028:合成タイプ別(バイオテクノロジー、合成)、製造業者タイプ別(内部消費用、販売用)、種類別、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆